SLPI: a new target for stopping metastasis.

Aging (Albany NY)

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Published: January 2018

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811255PMC
http://dx.doi.org/10.18632/aging.101372DOI Listing

Publication Analysis

Top Keywords

slpi target
4
target stopping
4
stopping metastasis
4
slpi
1
stopping
1
metastasis
1

Similar Publications

Many efforts have been made to reveal the mechanisms underlying skeletal muscle development because of its importance in animals. However, knowledge on chromatin accessibility, a prerequisite for gene expression, remains limited. Here, dynamic changes in chromatin accessibility were analyzed in the skeletal muscles of Min pigs at the ages of 30, 90, and 210 d using an assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq).

View Article and Find Full Text PDF

Introduction: Osteosarcoma (OS) is a malignancy of the bone that mainly afflicts younger individuals. Despite existing treatment approaches, patients with metastatic or recurrent disease generally face poor prognoses. A greater understanding of the tumor microenvironment (TME) is critical for enhancing outcomes in OS patients.

View Article and Find Full Text PDF

Druggable genes for therapeutic targeting in PTH signaling for osteoporosis.

Expert Opin Ther Targets

December 2024

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Science, Tokyo University of Science, Noda, Chiba, Japan.

View Article and Find Full Text PDF

A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration.

Cell Stem Cell

December 2024

State Key Laboratory of Organ Failure Research, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Academy of Orthopedics, Guangdong Province, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China. Electronic address:

Article Synopsis
  • This study focuses on improving cartilage regeneration using stem cells by addressing issues like off-target differentiation and hypertrophic tendencies.
  • Researchers created a system to monitor chondrogenesis and hypertrophy in real-time using stem cells with specific genetic markers and tested over 2,000 FDA-approved drugs.
  • They discovered that the drug phentolamine promoted cartilage growth and avoided degeneration, suggesting the α2-AR/SLPI pathway as a potential target for effective cartilage regeneration.
View Article and Find Full Text PDF

Background: Inorganic polyphosphates (polyPs) are linear chains of phosphates that accelerate blood clotting. Targeting polyP has been shown to reduce thrombosis.

Objectives: To identify and characterize anti-polyP monoclonal antibodies that could be used as analytical tools and as antithrombotic agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!